Article
Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors.
Journal of neural transmission (Vienna, Austria : 1996) - 1 Jan 2015
Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E
Abstract excerpt
The cytochrome P450 2D6 (CYP2D6) is involved in the metabolism of most antidepressants. Comedication with a potent CYP2D6 inhibitor can convert patients with extensive metabolizer (EM) or ultra-rapid metabolizer (UM) genotypes into poor metabolizer (PM) phenotypes. Since comedication is frequent in depressed patients treated with antidepressants, we investigated the effect of the CYP2D6 composite phenotype on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
